Emergence of Streptococcus pneumoniae serotype 19A (Spn19A) in the pediatric population in Bogotá, Colombia as the main cause of invasive pneumococcal disease after the introduction of PCV10
Introduction: With the use of pneumococcal conjugate vaccines(PCV), the behavior of invasive pneumococcal disease(IPD) has changed relative to serotype distribution. The introduction of these vaccines in national immunization programs has reduced the incidence of IPD, with a marked decrease in the c...
Main Authors: | Germán Camacho Moreno, Luisa F. Imbachi, Aura L. Leal, Vivian M. Moreno, Jaime A. Patiño, Iván F. Gutiérrez, Sandra Beltrán, Martha I. Álvarez-Olmos, Cristina Mariño, Rocío Barrero, Fabio Espinosa, Nicolás Ramos, Liliana P. Castellar, Nella Sánchez, Anita Montañez |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-09-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1710411 |
Similar Items
-
Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
by: Fakhrul Islam, et al.
Published: (2012-06-01) -
Changes in Invasive Pneumococcal Disease Caused by <em>Streptococcus pneumoniae</em> Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
by: Julia C. Bennett, et al.
Published: (2021-03-01) -
Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development [version 2; peer review: 2 approved]
by: Ahmed H. Radhi, et al.
Published: (2023-12-01) -
Pneumococcal serotype distribution: A snapshot of recent data in pediatric and adult populations around the world
by: Yadong A. Cui, et al.
Published: (2017-06-01) -
Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
by: Karin Bergman, et al.
Published: (2021-08-01)